Group 1 - The core product, the Tumi surgical robot, has surpassed 200 global commercial orders, covering nearly 50 countries and regions, with approximately 130 installations completed [1] - The increase in commercial orders and installations signifies the global recognition of Tumi's clinical value, demonstrating its safety, stability, and reliability [1] - In the nearly 50 countries covered, 12 have more than 5 orders, with strong growth in emerging markets like India (14 orders) and Brazil (over 10 orders), while developed markets like Spain and Australia are also experiencing rapid growth [1] Group 2 - The Tumi remote surgical robot is the first globally approved for commercial application, having received approval in nearly 10 countries, covering areas with nearly half of the world's population [2] - Tumi has completed nearly 800 remote surgeries across over 20 countries, maintaining a 100% success rate [2]